Cyclin dependent kinase inhibition: a novel treatment strategy for glioblastoma

被引：0

作者：

Murphy, B. ^{[1
]}

Noonan, J. ^{[1
]}

Jarzabek, M. ^{[1
]}

Lincoln, F. ^{[1
]}

Kavanagh, B. ^{[1
]}

Arhona, P. ^{[1
]}

Young, L. ^{[2
]}

Ligon, K. ^{[3
]}

Jahns, H. ^{[4
]}

Ashkenazi, A. ^{[5
]}

Zheleva, D. ^{[6
]}

Prehn, J. ^{[1
]}

Rehm, M. ^{[7
]}

Byrne, A. ^{[1
]}

机构：

[1] Royal Coll Surgeons Ireland, Physiol, Dublin, Ireland

[2] Royal Coll Surgeons Ireland, Surg, Dublin, Ireland

[3] Harvard Med Sch, Pathol, Boston, MA 02115 USA

[4] Univ Coll Dublin, Pathobiol, Dublin, Ireland

[5] Genentech Inc, Canc Immunol, San Francisco, CA USA

[6] Cyclacel, Res & Dev, Dundee, Scotland

[7] Univ Stuttgart, Cell Biol & Immunol, Stuttgart, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

106 (PB-05

引用

页码：E42 / E43

页数：2